We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-5.09%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$745M
AUM Growth
-$51.2M
Cap. Flow
-$4.97M
Cap. Flow %
-0.67%
Top 10 Hldgs %
3.53%
Holding
1,995
New
631
Increased
376
Reduced
341
Closed
636

Top Buys

Rank Stock Value
1
KOD icon
Kodiak Sciences
KOD
+$3.17M
2
CSTM icon
Constellium
CSTM
+$2.67M
3
KTB icon
Kontoor Brands
KTB
+$2.5M
4
SMTC icon
Semtech
SMTC
+$2.34M
5
CXT icon
Crane NXT
CXT
+$2.34M

Sector Composition

Rank Sector Weight
1 Healthcare 16.38%
2 Industrials 16.37%
3 Technology 14.13%
4 Consumer Discretionary 10.96%
5 Financials 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASTH icon
826
Astrana Health
ASTH
$1.85B
$331K 0.04%
+6,833
New +$353K
TTD icon
827
Trade Desk
TTD
$6.13B
$330K 0.04%
4,763
-4,068
-46% -$294K
CASS icon
828
Cass Information Systems
CASS
$736M
$329K 0.04%
8,920
-12,083
-58% -$482K
BWIN
829
Baldwin Insurance Group
BWIN
$2.79B
$329K 0.04%
+12,244
New +$353K
NEM icon
830
Newmont
NEM
$122B
$328K 0.04%
+4,129
New +$279K
OFIX icon
831
Orthofix Medical
OFIX
$418M
$328K 0.04%
+10,041
New +$323K
CRNX icon
832
Crinetics Pharmaceuticals
CRNX
$8.94B
$327K 0.04%
14,897
+2,562
+21% +$51.9K
MIRM icon
833
Mirum Pharmaceuticals
MIRM
$5.97B
$327K 0.04%
14,869
-8,232
-36% -$168K
HCA icon
834
HCA Healthcare
HCA
$89.3B
$326K 0.04%
+1,301
New +$327K
TNET icon
835
TriNet
TNET
$3.12B
$326K 0.04%
+3,315
New +$293K
TRUP icon
836
Trupanion
TRUP
$1.27B
$326K 0.04%
+3,653
New +$336K
BEKE icon
837
KE Holdings
BEKE
$19.6B
$325K 0.04%
26,284
+5,963
+29% +$106K
MIME
838
DELISTED
Mimecast Limited
MIME
$325K 0.04%
4,087
-6,409
-61% -$510K
CGNT icon
839
Cognyte Software
CGNT
$693M
$324K 0.04%
28,607
+1,946
+7% +$22.5K
SUPN icon
840
Supernus Pharmaceuticals
SUPN
$2.75B
$324K 0.04%
+10,023
New +$307K
ZIP icon
841
ZipRecruiter
ZIP
$409M
$324K 0.04%
+14,112
New +$306K
CTAS icon
842
Cintas
CTAS
$80.8B
$322K 0.04%
3,032
+940
+45% +$91.4K
MRNA icon
843
Moderna
MRNA
$23.6B
$322K 0.04%
+1,868
New +$314K
VNDA icon
844
Vanda Pharmaceuticals
VNDA
$298M
$322K 0.04%
28,482
+10,390
+57% +$137K
CPF icon
845
Central Pacific Financial
CPF
$989M
$321K 0.04%
+11,520
New +$333K
HRMY icon
846
Harmony Biosciences
HRMY
$2.28B
$321K 0.04%
6,600
+1,563
+31% +$63.7K
ACGL icon
847
Arch Capital
ACGL
$33.3B
$320K 0.04%
+6,610
New +$307K
J icon
848
Jacobs Solutions
J
$17.2B
$320K 0.04%
2,808
-4,131
-60% -$443K
MRIN
849
DELISTED
Marin Software
MRIN
$320K 0.04%
+18,503
New +$359K
ZBRA icon
850
Zebra Technologies
ZBRA
$17.9B
$320K 0.04%
774
-16
-2% -$7.35K

Similar funds

GSA Capital Partners's Q1 2022 Portfolio in Review

As of Q1 2022, GSA Capital Partners held 1,995 positions worth $745M, down 6.4% from $796M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

GSA Capital Partners's Q1 2022 filing shows 631 new, 376 increased, 341 reduced and 636 closed positions. Its largest new stake was Kodiak Sciences: 81,285 shares worth $628K. The largest sale was State Street Consumer Staples Select Sector SPDR ETF, an estimated $2.96M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.

  • GSA Capital Partners's largest Q1 2022 buy was Kodiak Sciences: 81,285 shares worth $628K.
  • GSA Capital Partners added most to UMB Financial in Q1 2022, an estimated $1.88M increase.
  • GSA Capital Partners's biggest Q1 2022 reduction was Cleveland-Cliffs, cutting an estimated $2.09M.
  • GSA Capital Partners fully exited State Street Consumer Staples Select Sector SPDR ETF in Q1 2022, selling an estimated $2.96M.
  • GSA Capital Partners's ten largest holdings make up 3.5% of its $745M portfolio in Q1 2022.
  • GSA Capital Partners opened 631 new positions and closed 636 in Q1 2022.
  • GSA Capital Partners's portfolio value fell 6.4% quarter-over-quarter to $745M.

Based on GSA Capital Partners's 13F filing for Q1 2022, filed 11 May 2022.